Wave Life Sciences (NASDAQ: WVE) — Perfil da empresa, notícias e dados financeiros
Wave Life Sciences focuses on advancing genetic medicines and developing innovative therapies for various diseases.
Wave Life Sciences
Wave Life Sciences (NASDAQ:WVE) is a biotechnology company focused on advancing the field of genetic medicines. Its operations revolve around developing innovative therapies using its proprietary chemistry platform, aimed at addressing unmet medical needs in various diseases. The company's projects include research and development in areas such as neuromuscular diseases, central nervous system disorders, and genetic skin diseases, with the objective of creating a pipeline of transformative drugs. Through collaboration and rigorous science, Wave Life Sciences aims to deliver life-changing treatments to patients worldwide. Wave Life Sciences is currently traded exclusively on the NASDAQ under the symbol WVE.
Resumo
Operações
Produtos e/ou serviços de Wave Life Sciences
- Development of innovative genetic medicines using proprietary stereopure oligonucleotide technology.
- Pipeline focused on treatments for genetic neurological disorders and liver diseases.
- Collaboration on exon skipping programs for Duchenne muscular dystrophy treatments.
- Research in therapies targeting central nervous system disorders including Alzheimer's and Huntington's diseases.
- Advancement of nucleic acid therapeutic candidates for genetically defined diseases.
- Partnership initiatives to leverage platform technology in developing precision medicine solutions.
equipe executiva do Wave Life Sciences
- Paul B. BolnoPresident, CEO & Director
- Gregory L. VerdineFounder & Director
- Kyle B. MoranCFO & Principal Accounting Officer
- Chandra VargeeseChief Technology Officer
- Christopher FrancisSenior VP of Corporate Development & Head of Emerging Areas
- Erik IngelssonChief Scientific Officer
- Kate RauschVic President of Corporate Affairs & Investor Relations
- Linda RockettSenior VP & General Counsel
- Katie SullivanSenior Director of Corporate Communications
- Daryn LewisSenior VP & Head of Human Resources
Principais indicadores financeiros
Resultados divulgados pela Wave Life Sciences, em USD.
- Cap. de mercado
- 680,4 mi
- Receita (TTM)
- 70,9 mi
- P/L
- —
- LPA (diluído, TTM)
- -1.1
- Dividend yield
- —
- Margem de lucro
- -296.9%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 42,7 mi | -215,4 mi | -204,4 mi | |
| 108,3 mi | -110,4 mi | -97 mi | |
| 113,3 mi | -68 mi | -57,5 mi | |
| 3,6 mi | -162,7 mi | -161,8 mi |